Skip to content
10-Q

Quarterly Report

Calidi Biotherapeutics, Inc. CLDI CLDWW

0001493152-25-022372

← back to feed
Filed
Nov 13, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 10, 2025 7.17M sh
Shares Diluted Q3 2025 · Sep 30, 2025 4.91K sh
Shares Diluted Q3 2025 · Sep 30, 2025 3.36K sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 652 sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 465 sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$16.25M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$14.27M
Long Term Debt Q3 2025 · Sep 30, 2025 $600K
Long Term Debt Q3 2025 · Dec 31, 2024 $600K
Short Term Debt Q3 2025 · Sep 30, 2025 $472K
Short Term Debt Q3 2025 · Dec 31, 2024 $3.22M
Stockholders Equity Q3 2025 · Sep 30, 2025 $6.92M
Stockholders Equity Q3 2025 · Dec 31, 2024 $1.53M
Current Liabilities Q3 2025 · Sep 30, 2025 $5.19M
Current Liabilities Q3 2025 · Dec 31, 2024 $9.5M
Total Liabilities Q3 2025 · Sep 30, 2025 $6.83M
Total Liabilities Q3 2025 · Dec 31, 2024 $12.21M
Current Assets Q3 2025 · Sep 30, 2025 $11.03M
Current Assets Q3 2025 · Dec 31, 2024 $10.23M
Total Assets Q3 2025 · Sep 30, 2025 $14.03M
Total Assets Q3 2025 · Dec 31, 2024 $14.18M
Eps Diluted Q3 2025 · Sep 30, 2025 −$2.21
Eps Diluted Q3 2025 · Sep 30, 2025 −$6.40
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$7.75
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$42.40
Eps Basic Q3 2025 · Sep 30, 2025 −$2.21
Eps Basic Q3 2025 · Sep 30, 2025 −$6.40
Eps Basic restated Q3 2025 · Sep 30, 2024 −$7.75
Eps Basic restated Q3 2025 · Sep 30, 2024 −$42.40
Sga Expense Q3 2025 · Sep 30, 2025 $2.69M
Sga Expense Q3 2025 · Sep 30, 2025 $8.4M
Sga Expense Q3 2025 · Sep 30, 2024 $3.07M
Sga Expense Q3 2025 · Sep 30, 2024 $10.69M
Rd Expense Q3 2025 · Sep 30, 2025 $2.36M
Rd Expense Q3 2025 · Sep 30, 2025 $7.38M
Rd Expense Q3 2025 · Sep 30, 2024 $2.15M
Rd Expense Q3 2025 · Sep 30, 2024 $7.06M
Net Income Q3 2025 · Sep 30, 2025 −$5.15M
Net Income Q3 2025 · Sep 30, 2025 −$15.85M
Net Income Q3 2025 · Sep 30, 2024 −$5.05M
Net Income Q3 2025 · Sep 30, 2024 −$18.05M
Operating Income Q3 2025 · Sep 30, 2025 −$5.05M
Operating Income Q3 2025 · Sep 30, 2025 −$15.77M
Operating Income Q3 2025 · Sep 30, 2024 −$5.23M
Operating Income Q3 2025 · Sep 30, 2024 −$17.75M